We tested the potential of piperazine-chitosans in siRNA silensing of EGFR, a pro-angiogenic factor up-regulated in non-small cell lung cancer (NSCLC), one of the most malignant forms of lung cancer. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.